RepliCel Announces its Incoming Board of Directors

Successful Annual General Meeting Confirms Director Slate for 2020 VANCOUVER, Dec. 23, 2019 /PRNewswire/ – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) (FRA:P6P2) (“RepliCel” or the “Company”), a company developing next-generation technologies in aesthetics and orthopedics, is…

About the Author

has written 20655 stories on this site.

Copyright © 2010-2019 strategicbusinessnews.com